LAKE FOREST, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that its executive team will host one-on-one investor and business development meetings in San Francisco January 9-11, 2023. The individual meetings will take place at the same time as the annual JP Morgan Healthcare Conference.
For more information and to schedule an investor meeting, please contact Matt Kreps, investor relations for Assertio, at mkreps@darrowir.com. To arrange a business development meeting, please contact Vanessa Fox, Vice President, Business Development and Commercial Analytics for Assertio, at vfox@assertiotx.com.
About Assertio
Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more visit www.assertiotx.com.
Investor Contact:
Matt Kreps
Managing Director
Darrow Associates
M: 214-597-8200
mkreps@darrowir.com
